New Zealand - English - Medsafe (Medicines Safety Authority)

haleon new zealand ulc - paracetamol 665mg;  ;  ;  ;  ; paracetamol 665mg; paracetamol 665mg - modified release tablet - 665 mg - active: paracetamol 665mg         excipient: carnauba wax croscarmellose sodium hypromellose   glycerol triacetate magnesium stearate povidone pregelatinised maize starch stearic acid active: paracetamol 665mg excipient: carnauba wax croscarmellose sodium hypromellose   glycerol triacetate magnesium stearate povidone pregelatinised maize starch stearic acid active: paracetamol 665mg excipient: carnauba wax croscarmellose sodium hypromellose   glycerol triacetate magnesium stearate povidone pregelatinised maize starch stearic acid - panadol osteo is effective for the relief of persistent pain associated with osteoarthritis and muscle aches and pains such as backache. panadol osteo also provides effective, temporary relief of pain and discomfort associated with headache, tension headache, period pain, toothache and pain after dental procedures, and cold & flu. reduces fever.

Australia - English - Department of Health (Therapeutic Goods Administration)

boucher & muir pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: water for injections; mannitol; sodium hydroxide; dibasic sodium phosphate dihydrate; povidone - paracetamol bnm 1000mg/100ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Australia - English - Department of Health (Therapeutic Goods Administration)

aft pharmaceuticals pty ltd - paracetamol, quantity: 10 mg/ml - injection, intravenous infusion - excipient ingredients: hydrochloric acid; cysteine hydrochloride monohydrate; dibasic sodium phosphate dihydrate; mannitol; nitrogen; water for injections; sodium hydroxide - paracetamol-aft 10mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; mannitol; water for injections; nitrogen - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; nitrogen; mannitol; water for injections - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; mannitol; water for injections; nitrogen - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

Australia - English - Department of Health (Therapeutic Goods Administration)

fresenius kabi australia pty ltd - paracetamol, quantity: 10 mg/ml - injection, solution - excipient ingredients: cysteine hydrochloride monohydrate; nitrogen; mannitol; water for injections - paracetamol 10 mg/ml, solution for infusion is indicated for the relief of mild to moderate pain and the reduction of fever where an intravenous route of administration is considered clinically necessary.

New Zealand - English - Medsafe (Medicines Safety Authority)

aft pharmaceuticals ltd - paracetamol 665mg;   - modified release tablet - 665 mg - active: paracetamol 665mg   excipient: croscarmellose sodium hypromellose opadry ii white 32f58900 magnesium stearate microcrystalline cellulose povidone pregelatinised maize starch - relief of persistent pain associated with osteoarthritis

Australia - English - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - paracetamol -

New Zealand - English - Medsafe (Medicines Safety Authority)

noumed pharmaceuticals limited - paracetamol 665mg - modified release tablet - 665 mg - active: paracetamol 665mg excipient: croscarmellose sodium hypromellose magnesium stearate maize starch opadry white oy-58900 povidone - effective for the relief of persistent pain associated with osteoarthritis for up to eight hours